Trial NCT01515046

View at ClinicalTrials.gov 
Org. Study IDs: 201204737
Secondary IDs: P30CA086862

Last trial update was posted on 2017-06-08

MeSH Interventions

Ascorbic Acid Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreatic Cancer

Stopping Reasons

Standard of care changed to FOLFIRINOX; poor accrual.

Limitations And Caveats

There was only one treated participant. Conclusions cannot be drawn from these data due to limited sampling size.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID